Diagnostics | Free Full-Text | Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review
CD20 expression and localization on WT Ramos B cells. (A) Flow... | Download Scientific Diagram
Detection of subsets of CD3+CD20+ T cells in healthy subjects. (A) (i)... | Download Scientific Diagram
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
CD20 expression by IHC and FCM of representative "dim" CD20 and... | Download Scientific Diagram
Detection of subsets of CD3+CD20+ T cells in healthy subjects. (A) (i)... | Download Scientific Diagram
Immunohistochemical staining for mono nuclear cell infiltration,... | Download Scientific Diagram
B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome | Nature Reviews Clinical Oncology
APC/CY7 Anti-Human CD20, B-Ly1 | SouthernBiotech
CD3xCD20 bsAb - Protheragen
IJMS | Free Full-Text | Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
Antibody drug development: Targeting CD20 and CD3
Immunohistochemical staining for Syk in reactive and neoplastic T... | Download Scientific Diagram
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys | Scientific Reports
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy | Scientific Reports
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies | Nature Reviews Neurology
Will Engineered T Cells Expressing CD20 scFv Eradicate Melanoma?: Molecular Therapy
Alexa Fluor 700 Anti-Human CD20, B-Ly1 | SouthernBiotech
CD20-positive T-cell lymphoma involving bone marrow: report of four cases | SpringerLink
Animals | Free Full-Text | Co-Expression of T- and B-Cell Markers in a Canine Intestinal Lymphoma: A Case Report
Targeting CD20 and CD3, the witness and creator in the process of antibody drug development - ACROBiosystems
Frontiers | A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
Antibody panel selection and lineage differentiation. In Bcell acute... | Download Scientific Diagram
Flow cytometric classification of CD20 levels. a Negative, no... | Download Scientific Diagram
